Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Shenkman Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Shenkman Capital Management
from 13F filings
Historical chart of Shenkman Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Shenkman Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3B | 900k | 1408.78 |
| 2025-06-30 | $5.3B | 4.2M | 1268.15 |
| 2025-03-31 | $9.4B | 7.2M | 1318.11 |
| 2024-12-31 | $14B | 12M | 1139.92 |
| 2024-09-30 | $6.7B | 5.6M | 1206.52 |
| 2024-06-30 | $6.2B | 5.5M | 1139.46 |
| 2024-03-31 | $5.5B | 5.5M | 998.96 |
| 2023-12-31 | $5.0B | 5.2M | 948.12 |
| 2023-09-30 | $4.0B | 4.2M | 950.82 |
More positions owned by Shenkman Capital Management
View all positions for Shenkman Capital Management
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1